English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Book Chapter

Multimodality imaging: Overview of imaging techniques (CT, MRI, PET, optical imaging) and impact of multimodality imaging on drug development

MPS-Authors
/persons/resource/persons147331

Waerzeggers,  Yannic
Gentherapie und Molekulare Bildgebung, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147244

Monfared,  Parisa
Gentherapie und Molekulare Bildgebung, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147322

Ullrich,  Roland
Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147328

Viel,  Thomas
Gentherapie und Molekulare Bildgebung, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Waerzeggers, Y., Monfared, P., Ullrich, R., & Viel, T. (2012). Multimodality imaging: Overview of imaging techniques (CT, MRI, PET, optical imaging) and impact of multimodality imaging on drug development. In P. H. Elsinga, A. Van Waarde, A. Paans, & R. Dierckx (Eds.), Trends on the role of PET in drug development (pp. 319-382). World Scientific Publ.


Cite as: https://hdl.handle.net/21.11116/0000-0008-DEE5-C
Abstract
There is no abstract available